We are a CRO specialising in the analysis of proteins and their associated PTM’s via advanced Mass Spectrometry.  By using proprietary methodologies, we can detect up to 8,000 proteins per sample in Discovery mode and can offer multiplexed assays of up to 100 proteins/sample in a GCLP accredited Targeted assay.

With their proprietary bioinformatics software, these can be trimmed down to some tens of proteins that are either up-, or down-regulated with disease progression or drug treatment.

At Novogene, as a certified Illumina Genome Network member, we are focused on partnering with you to further your research utilizing the latest in NGS technologies. Having worked on more than 1,259,000 samples with a total data output of over 21,476 TB, our strong scientific expertise and experience is an advantage our clients leverage to meet their project goals, and has resulted in 29 NGS-related patents, with over 560 research papers in high impact journals with total impact factor at more than 4920. We offer a range of NGS-based services for human, plant, animal and microbial DNA and RNA analysis at highly competitive prices, with industry leading turnaround times, Q30 guarantee that exceeds even Illumina’s own, customer service that is second to none and can meet any project need you may have. With that said, we would love to hear about your project and offer solutions to meet your needs. We are here for you.

With unwavering commitment, expertise and infrastructure we fuel and strengthen the life science market with our offering of contract manufacturing services for our visionary partners. As a trusted and reliable resource, our goal is to set the standard for partnership excellence in life science.

PerkinElmer, Inc. offers innovative solutions which improve the efficiency of genomic and proteomic workflows while eliminating the challenges associated with them. The HIVE™ scRNAseq solutions for single cell genetic analysis facilitates the remote collection, storage, and shipment of samples for central processing enabling labs to process samples when they want without specialized instrumentation.

Mission Bio is a life sciences company that accelerates discoveries and cures by equipping researchers with the tools they need to improve how we measure and predict our resistance and response to precision therapies. With the Tapestri Platform, the only commercialized platform capable of analyzing DNA and protein simultaneously with single-cell resolution, Mission Bio’s multi-omics approach improves time-to-market for new therapeutics, including innovative cell and gene therapies that provide new pathways to health.